Search clinical trials for: Performance Status
Total 8488 results
-
New York Presbyterian Brooklyn Methodist HospitalCompletedPain | Cancer | MetastasisUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.CompletedHematologic Malignancies | Malignant Solid TumorUnited States
-
Bern University of Applied SciencesCompletedMuscle Weakness | Poor Performance StatusSwitzerland
-
Bern University of Applied SciencesSwiss Federal Institute of TechnologyCompletedPoor Performance Status | Cognition - OtherSwitzerland
-
University College, LondonBoehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited Kingdom
-
CelgeneCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Hospices Civils de LyonCompleted
-
IRCCS Policlinico S. DonatoCompleted
-
Wake Forest UniversityCompletedAcute Respiratory FailureUnited States
-
Silesian University of MedicineCompletedQuality of Life | Breast Cancer | Palliative Care | Cancer, Breast
-
GlaxoSmithKlineCompletedNutritional Status | Physical FitnessIndia
-
University of California, DavisCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Cognitive/Functional Effects | Long-term Effects Secondary to Cancer Therapy in Children | Long-term Effects Secondary to Cancer Therapy in Adults and other conditionsUnited States
-
University of BurgundyCompleted
-
Cedars-Sinai Medical CenterCompleted
-
Boehringer IngelheimTerminatedAfatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)Carcinoma, Non-Small-Cell Lung | ErbB ReceptorsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLeukemia | Breast Cancer | Multiple Myeloma | Colorectal Cancer | Lung Cancer | Prostate CancerUnited States
-
Bangor UniversityUniversity of East Anglia; University of ManchesterUnknown
-
National Cancer Institute, NaplesGruppo Oncologico Italia Meridionale; Gruppo Italiano per lo studio dei Carcinomi... and other collaboratorsTerminatedNon-Small Cell Lung CancerItaly
-
Florida State UniversityCompleted
-
M.D. Anderson Cancer CenterEli Lilly and CompanyCompletedLung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedChronic Myeloid LeukemiaUnited States
-
Jimma UniversityUnknown
-
Universidade do PortoCenter for Health Technology and Services ResearchCompletedUrinary Iodine Status in School Aged ChildrenPortugal
-
Bern University of Applied SciencesGoethe University; Maastricht University Medical Center; Swiss Federal Institute...CompletedMuscle Weakness | Poor Performance StatusSwitzerland
-
National Institute of Nutrition and Seafood Research...University of Tromso; NORCE Norwegian Research Centre ASCompletedHealth Behavior | Cognitive Performance | Nutrient StatusNorway
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Terminated
-
Bern University of Applied SciencesGoethe University; Maastricht University Medical Center; Swiss Federal Institute...CompletedPoor Performance StatusSwitzerland
-
University of UtahCompleted
-
SCRI Development Innovations, LLCGenentech, Inc.Completed
-
National Institute of Medical Sciences and Nutrition...Withdrawn
-
Ass. Prof. Jan NymanTerminatedNon Small Cell Lung Cancer | Locally Advanced DiseaseSweden
-
Universität des SaarlandesCompletedHealth Status | Maximal and Submaximal Parameters of Physical PerformanceGermany
-
Clinical Research Support Center KyushUnknown
-
University of MinnesotaCompleted
-
University of Sao PauloCompleted
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI); Pediatric Heart NetworkCompletedArrhythmia | Defect, Congenital Heart
-
Mondelēz International, Inc.St. John's Research InstituteCompleted
-
Makerere UniversityUniversity of Bergen; Centre MurazUnknownMalnutrition | Neurologic Deficits | Poor Performance Status | Infections, Hospital | Mixed Behavior and Emotional DisorderUganda
-
All India Institute of Medical Sciences, New DelhiCompleted
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Instituto Nacional de Cancer, BrazilEli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBrazil, United States
-
Appalachian State UniversityDole Food CompanyCompletedMuscle Soreness | Vitamin D Status | Muscle FunctionUnited States
-
Democritus University of ThraceCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Intgracellular Signaling in Skeletal Muscle | Inflammatory StatusGreece
-
University of FloridaCompletedCancerUnited States
-
Institut de Recherche pour le DeveloppementGlobal Alliance for Improved Nutrition; National Institute of Nutrition, Vietnam and other collaboratorsCompletedCognitive PerformanceVietnam
-
OSI PharmaceuticalsCompleted
-
Holux Technology, Inc.Shin Kong Wu Ho-Su Memorial HospitalUnknownIndication for Modification of Patient's Cardiopulmonary StatusTaiwan
-
Jay F. Piccirillo, MDUniversity of Alabama at BirminghamCompletedHead and Neck CancerUnited States
-
University of Wisconsin, MadisonTerminatedNon Small Cell Lung CancerUnited States